AXSR Session 4 Highlights: Platform Trials

Ax-S Thursdays

AXSR Session 4 Highlights: Platform Trials
AXSR Session 1: Expanded Access and COVID19
AXSR Session 2: Real World Data from Hybrid Trials
AXSR Session 3: Decentralized Clinical Trials
AXSR Session 4: Platform Trials
AXSR Session 2: Tobias Polak, Real World Data from EAPs
AXSR Session 2: Dr. Amy Abernethy, the Learning Health System
AXSR Session 4: Dr. Merit Cudkowicz, Platform Trial in ALS

Expanded Access Summit 3.0

EA3 Trailer Excerpt Dr. Anthony Fauci
EA3 Dr. Anthony Fauci
EA3 Dr. Janet Woodcock
EA3 Dr. Michael Kurilla (NCATS)
EA3 Dr. Hilary Marston (NIAID)
EA3 Dr. Robert Walker (BARDA)
EA3 Sessions 1 & 2 Fulfilling the Promise of Expanded Access
EA3 Session 3 Beyond the Simple Narratives
EA3 Session 4 Reimbursement for Exploratory Treatment Access
EA3 Session 6 The Integration of Research and Treatment
EA3 Session 7 Life Science and Healthcare Partnerships for Access
EA3 Session 8 Pre-Market Access for Population Needs and Contagion Outbreaks

Case Reviews

Excerpt of Ax-S Thursdays Gleevec Interview
Ax-S Thursdays Case Review of Novartis Gleevec EAP
Excerpt of Ax-S Thursdays Ulixertinib Interview
Ax-S Thursdays Case Review of BVD Ulixertinib EAP
Excerpt of Ax-S Thursdays Dojolvi Interview
Ax-S Thursdays Case Review of Ultragenyx Dojolvi EAP

Explainers

Real World Evidence from Expanded Access Programs
AXSR Session 2: Tobias Polak, Real World Data from EAPs
AXSR Session 2: Dr. Amy Abernethy, the Learning Health System
Expanded Access Explained in 4 Minutes
The Difference Between Cohort and Single-Patient Expanded Access

EA Summit 1.0 (2017)

EA1 (2017) Keynote, David Farber
EA1 (2017) Session 1, The First 30 Years of Expanded Access
EA1 (2017) Session 2, Operationalizing Expanded Access
EA1 (2017) Session 3, Economically Sustainable Access Programs
EA1 (2017) Session 4, Real World Evidence from EAPs
EA1 (2017) Session 5, Supporting Clinical Research with EAPs

Promos and Vlogs

AXSR Session 4 Highlights: Platform Trials
AXSR Innovator Showcase: xCures
EA3 Trailer Excerpt: Dr. Hilary Marston
EA3 Trailer Excerpt: Dr. Michael Kurilla
EA3 Trailer Excerpt: Dr. Janet Woodcock
Excerpt of Ax-S Thursdays Gleevec Interview
Excerpt of Ax-S Thursdays Ulixertinib Interview
Excerpt of Ax-S Thursdays Dojolvi Interview
Why Expanded Access Matters to Me
The First Expanded Access Summit (2017)

90 second highlight reel of March 25 Ax-S Thursdays Session.

Michael Kurilla, MD, PhD (NCATS / NIH)
Merit Cudkowicz, MD (Mass General Hospital, Harvard Med School)
Suanna Bruinooge, MPH (American Society of Clinical Oncology)
Kevin Weatherwax (University of Michigan Medical System)